Culture-sensitive Emotion Regulation Group Therapy for Traumatized Refugees

April 2, 2019 updated by: Theresa Koch, Ludwig-Maximilians - University of Munich

Culture-sensitive Emotion Regulation Group Therapy for Traumatized Refugees: A Randomized Controlled Trial

There is a lack of studies on treatment effect in traumatised refugees. Recent findings indicate that emotion regulation deficits play a key role in PTSD also among traumatized refugees and highlight the importance and potential directions for the development of an emotion regulation training for refugees. In this study, the investigators therefore want to examine the effectiveness of a new, transdiagnostic, cultural-sensitive group therapy, which systematically teaches specific emotion regulation strategies. Participants will be randomly assigned to either the emotion regulation training, delivered in group format or a wait list control condition. The study takes place in cooperation with REFUGIO Munich, which is a treatment centre specialised in the treatment of traumatised refugees. Clinicians will deliver the treatment to traumatized asylum seekers and refugees that report difficulties in emotion regulation. The investigators will examine if refugees and asylum seekers in the intervention group will show improvements in psychological symptoms, social functioning as well as in emotion regulation in comparison to a wait list control group which will receive the treatment after the intervention group has completed. The group therapy covers 14 sessions and has a cognitive-behavioural background. It focuses on conveying strategies to cope with intense feelings and the patients should gain a sense of self-efficacy and control over their trauma-relevant feelings and symptoms. Qualified interpreters will be used in the assessments as well as group therapies.

Study Overview

Study Type

Interventional

Enrollment (Actual)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Munich, Germany
        • REFUGIO München

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 21 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Refugee or asylum seeker from Afghanistan, speaking Dari
  • reporting at least one traumatic event on a trauma list
  • reporting difficulties in emotion regulation
  • between the age of 15 and 21 years

Exclusion Criteria:

  • Psychosis
  • Serious suicidal ideations
  • Currently receiving psychotherapy elsewhere
  • Serious dissociation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Emotion Regulation Group Therapy
Participants assigned to this condition will receive treatment immediately after assignment.
Emotion Regulation Group Therapy, 14 sessions, 1.5 hour sessions, group therapy, meeting weekly.
Other Names:
  • German title: Skills-Training der Affektregulation: Ein kultursensibler Ansatz: STARK
No Intervention: Wait List Control
This condition is a wait-list control and receives no intervention during the study period, but is offered treatment after the final assessment directly after the treatment phase of the intervention group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Difficulties in Emotion Regulation
Time Frame: baseline, after 14 weeks (= post-treatment), 3-months-follow-up (3 months after the treatment)
Scale: Emotion Regulation Scale (DERS)
baseline, after 14 weeks (= post-treatment), 3-months-follow-up (3 months after the treatment)
Change in General Health
Time Frame: baseline, after 14 weeks (= post-treatment), 3-months-follow-up (3 months after the treatment)
Scale General Health Questionnaire -28 (GHQ-28)
baseline, after 14 weeks (= post-treatment), 3-months-follow-up (3 months after the treatment)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in posttraumatic stress
Time Frame: baseline, after 14 weeks (= post-treatment), 3-months-follow-up (3 months after the treatment)
Scale: PTSD Checklist for DSM-5 (PCL-5)
baseline, after 14 weeks (= post-treatment), 3-months-follow-up (3 months after the treatment)
Change in Anger Reactions
Time Frame: baseline, after 14 weeks (= post-treatment), 3-months-follow-up (3 months after the treatment)
Scale: Dimensions of Anger Reactions-5 (DAR-5)
baseline, after 14 weeks (= post-treatment), 3-months-follow-up (3 months after the treatment)
Treatment Experience Scale - Patient (TESP)
Time Frame: after 14 weeks (= post-treatment)
after 14 weeks (= post-treatment)
Change in emotional competence (Third party assessment by caregiver)
Time Frame: baseline, after 14 weeks (= post-treatment), 3-months-follow-up (3 months after the treatment)
Scale: Emotional Competence Questionnaire (German: Emotionale-Kompetenz-Fragebogen - Fremdbeurteilung (EKF))
baseline, after 14 weeks (= post-treatment), 3-months-follow-up (3 months after the treatment)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Alexandra Liedl, PhD, REFUGIO München
  • Study Director: Theresa Koch, M.Sc., Ludwig-Maximilians-Universität München/ REFUGIO München
  • Study Chair: Thomas Ehring, Professor, Ludwig-Maximilians-Universität München

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2017

Primary Completion (Actual)

December 21, 2018

Study Completion (Actual)

February 1, 2019

Study Registration Dates

First Submitted

May 18, 2017

First Submitted That Met QC Criteria

May 19, 2017

First Posted (Actual)

May 22, 2017

Study Record Updates

Last Update Posted (Actual)

April 3, 2019

Last Update Submitted That Met QC Criteria

April 2, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 022ERT

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Trauma

Clinical Trials on Skills training of Affect-Regulation - A culture-sensitive approach: STARK

  • Seattle Children's Hospital
    National Institute on Drug Abuse (NIDA); University of Washington; Michigan State... and other collaborators
    Recruiting
    Substance Use Disorders | Recidivism
    United States
3
Subscribe